T1	Participants 316 449	A randomized, blinded trial in 217 postmenopausal women with hot flushes randomized to 5 or 10 g/day of MF101 or placebo for 12 weeks
T2	Participants 549 671	mean percent decrease in frequency of hot flushes in the 10 g/day group was 12.9% greater than that in the placebo group (
T3	Participants 682 758	the median percent decrease was 11.7% greater than that in the placebo group
T4	Participants 775 904	the proportion of women with at least a 50% reduction in hot flushes was 16.2% greater than that in the placebo group (P = 0.03).
